Relationship between the structure and immunogenicity of ceftriaxone

W Arjharn, V Vongsutilers, P Thantiworasit, N Suthumchai, J Klaewsongkram, B Tuesuwan

Abstract


Ceftriaxone is one of the most reported cause allergic reaction due to frequently prescribed.(1) Once the patients are suspected to ceftriaxone allergy, we must be concerned with cross-allergic reaction to cephalosporins and other β-lactam antibiotics. The relationship between structure and immunogenicity of β-lactam antibiotics could be beneficial for drug treatment selection. Several studies have attempted to reveal the structure of cephalosporins that involved the allergic reaction and cross reaction to other β-lactam antibiotics by skin test, re-challenge test, and radioimmunoassay on IgE determination.(2-6) These methods have disadvantages such as invasion or limitation of time interval from allergen exposure.(7) The in vitro immunoassay for instance enzyme-linked immunosorbent spot (ELISPOT) is an optional method to investigate the allergic reaction due to specificity and non-invasive.(8) Our objective is to investigate the relationship between structure of ceftriaxone and its immunogenicity using ELISPOT IFN-γ assay. The tested compounds are including native molecule of ceftriaxone, its side chain moieties, degradation products, and other native cephalosporins.


Full Text:

5-8

References


Qing-Ping S, Xiao-Dong J, Feng D, Mei-Ling Y, Shu-Qiang Z. Adverse Drug Reactions and Pattern Use of Cephalosporins: A Retrospective Review of Hospitalized Patients During 5 Years. International Journal of Pharmacology. 2013;9(1):66-73.

Pham NH, Baldo BA. β-Lactam drug allergens: Fine structural recognition patterns of cephalosporin-reactive IgE antibodies. Journal of Molecular Recognition. 1996;9(4):287-96.

Sánchez-Sancho F, Perez-Inestrosa E, Suau R, Montañez MI, Mayorga C, Torres MJ, et al. Synthesis, Characterization and Immunochemical Evaluation of Cephalosporin Antigenic determinants. Journal of Molecular Recognition. 2003;16(3):148-56.

Antunez C, Blanca-Lopez N, Torres MJ, Mayorga C, Perez-Inestrosa E, Montanez MI, et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. Journal of Allergy and Clinical Immunology. 2006;117(2):404-10.

Guéant J-L, Guéant-Rodriguez R-M, Viola M, Valluzzi RL, Romano A. IgE-mediated hypersensitivity to cephalosporins. Current pharmaceutical design. 2006;12(26):3335-45.

Montanez MI, Mayorga C, Torres MJ, Ariza A, Blanca M, Perez-Inestrosa E. Synthetic approach to gain insight into antigenic determinants of cephalosporins: In Vitro studies of chemical structure-IgE molecular recognition relationships. Chemical Research in Toxicology. 2011;24(5):706-17.

Romano A, Gaeta F, Valluzzi RL, Zaffiro A, Caruso C, Quaratino D. Natural evolution of skin-test sensitivity in patients with IgE-mediated hypersensitivity to cephalosporins. Allergy. 2014;69(6):806-9.

Ebo DG, Leysen J, Mayorga C, Rozieres A, Knol EF, Terreehorst I. The in vitro diagnosis of drug allergy: status and perspectives. Allergy. 2011;66(10):1275-86.

Tanvarasethee B, Buranapraditkun S, Klaewsongkram J. The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems. Acta dermato-venereologica. 2013;93(1):66-9.


Refbacks

  • There are currently no refbacks.